SAN DIEGO, Aug. 6, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today reported operating highlights and financial results for the second quarter and six months ended June 30, 2012.
"The first half of the year proved to be an important turning point for Verenium," said James Levine, President & Chief Executive Officer at Verenium. "With the recent move into our new facility completed and our debt repaid, we are focused on growing our business through the sales of our current marketed products, developing our product pipeline, and establishing future collaborations and partnerships."
Company HighlightsSince the beginning of 2012, the Company has made progress on both operational and financial fronts. Recent accomplishments include:
Completed a strategic transaction with DSM Food Specialties, B.V. ("DSM"), including the sale of the Company's oilseed processing business, for total consideration of $37 million;
Repurchased $34.9 million in convertible notes outstanding, retiring all of the Company's remaining debt;
Announced that the Company's next-generation enzyme breaker was authorized for use in hydraulic fracturing by the Environmental Protection Agency (EPA);
Completed moving into the Company's new office and state-of-the-art laboratory and pilot plant facility in San Diego, California; and
Ended the second quarter with unrestricted cash of $14.4 million and $5.7 million in restricted cash.
Financial ResultsIn the commentary below, the operating results of the Company's oilseed processing business, sold to DSM in March 2012, for prior periods are included in continuing operations.
Revenues for the periods ended June 30, 2012 and 2Page: 1 2 3 4 5 6 7 8 9 10 Related biology technology :1
. Verenium Corporation To Announce Second Quarter 2012 Financial Results2
. Verenium Announces EPA Authorization To Market Its Next-Generation Enzyme Breaker For Hydraulic Fracturing3
. Verenium Corporation And Alexandria Real Estate Equities, Inc. Celebrate The Grand Opening Of A New State-of-the-art Biotechnology Facility4
. Verenium Corporation Named One Of The 2012 Best Places to Work in San Diego5
. Verenium Corporation To Announce First Quarter 2012 Financial Results6
. Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results7
. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration8
. Verenium to Present at Baird Clean Technology Conference9
. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 201110
. Cadence Pharmaceuticals Reports Second Quarter 2012 Financial Results11
. Discovery Labs Reports Second Quarter 2012 Financial Results